PTEN and Familial prostate cancer: As shown in Figure 5B, although both gene expression-based (green bars) and TFA-based (gold bars) breast PTEN IHC-based signatures can be used to predict PTEN status by unsupervised clustering approach in human breast cancers, they failed to do so for prostate cancers and brain tumors.